» Articles » PMID: 17167246

Depressive Symptoms in Machado-Joseph Disease (SCA3) Patients and Their Relatives

Overview
Journal Community Genet
Publisher Karger
Specialty Health Services
Date 2006 Dec 15
PMID 17167246
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: It was the aim of this study to determine the depression scores of Machado-Joseph disease (MJD) patients, their spouses, and individuals at 50% risk for MJD, and second, to verify the existence of a correlation between depressive symptoms and the degree of motor incapacitation.

Subjects And Methods: Two hundred and forty-six individuals aged > or =18 years were studied: 79 MJD patients (group 1), 43 spouses of MJD patients (group 2), 80 individuals at risk for MJD (group 3), and a control group (group 4) composed of 44 patients with multiple sclerosis (MS). The following two tools were applied: the Beck Depression Inventory and the Barthel index of physical incapacitation, both in an adapted Brazilian Portuguese version.

Results: Moderate to severe depressive scores were found in 33.5% of patients in the MJD families, in 16.3% of the spouses, and in 6.3% of the individuals at risk. This linear reduction between MJD family members was statistically significant (p < 0.0001, ANOVA). Depressive scores were also associated with age and the female sex. A direct correlation between Beck Depression Inventory scores and motor incapacitation was found in MJD patients (r = 0.507, Pearson correlation, p < 0.0001). Although the depressive symptoms in the control group with MS were higher than those found in MJD patients (59% of MS patients showed moderate to severe scores), depression did not correlate with physical incapacitation, age, or education attainment in the MS group.

Conclusions: Depressive symptoms are rather common in MJD patients and in their spouses (caregivers). In this condition, depression seemed to be more reactive than primarily related to the disease process itself.

Citing Articles

Cognitive, Emotional, and Other Non-motor Symptoms of Spinocerebellar Ataxias.

Lin C, Kuo S, Opal P Curr Neurol Neurosci Rep. 2024; 24(3):47-54.

PMID: 38270820 PMC: 10922758. DOI: 10.1007/s11910-024-01331-4.


The Homogeneous Azorean Machado-Joseph Disease Cohort: Characterization and Contributions to Advances in Research.

Lima M, Raposo M, Ferreira A, Melo A, Pavao S, Medeiros F Biomedicines. 2023; 11(2).

PMID: 36830784 PMC: 9953730. DOI: 10.3390/biomedicines11020247.


Mindfulness-Based Stress Reduction in Pre-symptomatic Genetic Frontotemporal Dementia: A Pilot Study.

Poos J, van den Berg E, Papma J, van der Tholen F, Seelaar H, Donker Kaat L Front Psychiatry. 2022; 13:864391.

PMID: 35573340 PMC: 9091907. DOI: 10.3389/fpsyt.2022.864391.


A Young Japanese Patient with Spinocerebellar Ataxia Type 3 Presenting Depressive State with Cenesthopathy and Delusion: a Case Report.

Okamoto N, Ikenouchi A, Ide S, Hashimoto Y, Yoshimura R Cerebellum. 2021; 21(6):1135-1138.

PMID: 34705199 PMC: 9596515. DOI: 10.1007/s12311-021-01338-4.


Anxiety and depression in spinocerebellar ataxia patients during the COVID-19 pandemic in China: A cross-sectional study.

Gong Y, Chen Z, Liu M, Wan L, Wang C, Peng H J Clin Neurosci. 2021; 88:39-46.

PMID: 33992201 PMC: 9759361. DOI: 10.1016/j.jocn.2021.03.004.